| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |